Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Mott MacDonald Ltd
Street 1: 10 Fleet Place
Street 2:
City: London
Province:
Post Code: EC4M 7RB
Country: United Kingdom of Great Britain and Northern Ireland
Phone: +44 (0) 207 651 0302
Organization Email: viv.wight@mottmac.com
Web Site: http://www.mottmac.com
Other Online Presence:

Focal Point Contact Information

Salutation: Mrs
First Name: Vivien
Last Name: Wight
Title: Business Development Consultant
Email: viv.wight@mottmac.com
Phone: +44 (0) 207 651 0302

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Ken
Last Name: Grant
Title: Technical Director - International Health Division
Email: ken.grant@mottmac.com
Phone: +44 (0) 207 651 0302

General Information

Board Constituency: Private sector
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
HLSP provides health sector consultancy, programme management and policy advice to international agencies and national governments in developing countries.
Our expertise ranges from health systems strengthening to cross-cutting issues related to aid effectiveness.

HLSP is supported by an in-house team of technical specialists and 8000 external consultants offering a broad range of health sector skills including health policy and planning, sector financing, governance, gender, and capacity development.

Our expertise includes:

identifying target and risk groups
designing disease control programmes and supporting the integration of disease control interventions into health systems strengthening efforts
adapting the financing of communicable disease control to broader health sector financing modalities
evaluating financial and technical support for communicable diseases
Examples:

Regional Public Goods for Health: Combating Dengue in ASEAN
Mozambique: Appraisal of the DFID-Funded Insecticide Treated Nets Distribution
Partnerships for Malaria Control: Engaging the Formal and Informal Private Sectors
Independent Evaluation of the Global Outbreak Alert and Response Network (GOARN)
South Africa: Development and Field Testing of WHO Tuberculosis Costing Tool
South Africa: Rapid Response Health Fund (TB)
Review of the International Union against TB & Lung Disease, Review of STOP TB Partnership


We have previous experience of TB control namely: Independent external evaluation of the Global Stop TB Partnership Commissioned by the Stop TB Partnership Secretariat at WHO, 2003 and we are currently involved in a TB Reach project together with the Royal Tropical Institute.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Advocacy
Funding, including innovative and optimized approach to funding TB Care
Research and Development
Technical Assistance

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Technical assistance and advice
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
External Review of Grant Framework for Public-Private Product Development Partnerships
Region: -
Country: -
Client: Ministry of Foreign Affairs, The Netherlands
Date: 2009

In 2006, the Netherlands Ministry of Foreign Affairs awarded eight grants to public-private Product Development Partnerships (PDPs) working on the development of medicines, vaccines and diagnostics for AIDS, TB and malaria. PDPs bring together public and private partners to work towards a common goal of developing new and improved health technologies to address the world’s most neglected diseases. HLSP was contracted to review the grant mechanism to assess the effectiveness and efficiency of the use of the Dutch funds and their impact on each PDP.

Technical area:

Access to medicines
Monitoring and evaluation
Private sector


Independent external evaluation of the Global Stop TB Partnership
Region: -
Country: -
Client: Stop TB Partnership Secretariat at WHO
Date: 2003

HLSP conducted an external evaluation of the Partnership's relevance, efficacy, efficiency, sustainability, institutional development impact, process, governance and implementation. The evaluation included country case studies (Russian Federation, Cambodia, South Africa, Indonesia, Brazil, Afghanistan).

Read the evaluation report.

Technical area:

Monitoring and evaluation
TB, malaria and other communicable diseases

 

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Albania
Australia
Bangladesh
Belize
Bosnia and Herzegovina
Cambodia
India
Kazakhstan
Kenya
Nepal
Netherlands
Nigeria
Pakistan
Philippines
South Africa
United Kingdom of Great Britain and Northern Ireland
Viet Nam
Zambia

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Along with KIT, we carry out the monitoring and evaluation of TB REACH grantees' projects (waves 1-3). The expansion and enhancement aspect is reflected in TB-REACH's objectives of increasing case detection, treatement and cures, using innovative or tried and tested ways of reaching previously unreached populations.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: September 27, 2010
Last updated: May 3, 2017